Dymes Pharmachem Limited - pharma in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U51909TG1992PLC014888 Incorporated 16 October 1992 ROC Hyderabad HQ Hyderabad, Telangana, India
Merged Public Limited Company pharma
Data last updated
Revenue · FY 2015
₹13.33 Cr
▼ 17% YoY
EBITDA · FY 2015
₹1.09 Cr
EBITDA margin 8.2%
Authorised capital
₹4.5 Cr
Registered with MCA
Paid-up capital
₹4.5 Cr
Issued & subscribed
Satisfied charges
₹5.95 Cr
No open charges
Company age
34 yrs
Est. 1992
Directors on board
3
As per MCA filings
Brands
1
Associated brands

About Dymes Pharmachem Limited

Data last updated:

Dymes Pharmachem Limited was a public limited company based in Hyderabad, Telangana, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 October 1992.

The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TG1992PLC014888.

The company had an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹4.5 Cr. It was led by directors including Kallam Subbareddy (Managing Director) and Kallam Krishna Chaitanya (Whole-Time Director).

Its last annual general meeting (AGM) was held on 28 September 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office was at Plot No 33 S.V. Cooperative Industrial Estate. Jeedimetla, Hyderabad, Telangana, India – 500055.

As per the financials filed for FY 2015, the company reported a revenue of ₹13.33 Cr, a decline of 17% compared to the previous year. For the same year it recorded EBITDA of ₹1.09 Cr (EBITDA margin 8.2%).

The company was associated with 1 brand: Dymes Pharmachem. As per MCA filings, the company had satisfied charges of ₹5.95 Cr on record. Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it.

The last known website on record is dymespharmachem.com.

Company details

CIN U51909TG1992PLC014888
Registration Number 014888
Incorporation Date 16 October 1992
ROC Hyderabad
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 28 September 2015
Date of Balance Sheet 31 March 2015

CIN history

Dymes Pharmachem has one previous CIN (Corporate Identification Number): U51909AP1992PLC014888. The current CIN is U51909TG1992PLC014888, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U51909TG1992PLC014888Current
U51909AP1992PLC014888Previous

Contact details

Dymes Pharmachem Limited's registered office is in Hyderabad, Telangana.

  • Registered Address
    Plot No 33 S.V. Cooperative Industrial Estate. Jeedimetla, Hyderabad, Telangana, India – 500055
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Dymes Pharmachem Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Dymes Pharmachem operates one associated brand: Dymes Pharmachem. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures active pharmaceutical ingredients and intermediates.dymespharmachem.com

Financials of Dymes Pharmachem Limited

FY 2015 filings available

Dymes Pharmachem Limited reported revenue of ₹13.33 Cr (down 17% YoY) for FY 2015.

Revenue · FY 2015
₹13.33 Cr ▼ 17%
EBITDA · FY 2015
₹1.09 Cr margin 8.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 17%
EBITDA CAGR growth
1 year
▼ 1%

Revenue fell 17% in the latest year. EBITDA fell 1% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2014-15
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.09 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2014-15
Profitability
EBITDA Margin8.2%
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dymes Pharmachem Limited, buy the company report.

Board of directors of Dymes Pharmachem Limited

Dymes Pharmachem has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Kallam SubbareddyManaging Director01 Nov 201411 Years 11 MonthsAs last reported
Kallam Krishna ChaitanyaWhole-Time Director01 Nov 201411 Years 11 MonthsAs last reported
Shilpi SinghDirector01 Nov 201411 Years 11 MonthsAs last reported

Peer comparison

Dymes Pharmachem Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Seagull Laboratories (India) Private Limited₹13.38 Cr (FY 2024)-2.0%New Delhi, Delhi, India
Southern Union Pharmaceuticals Kerala Private Limited₹13.37 Cr (FY 2025)-10.0%Thrissur, Kerala, India
Medoz Pharmaceuticals Private Limited₹13.36 Cr (FY 2025)6.0%Vadodara, Gujarat, India
Navin Saxena Research and Technology Private Limited₹13.34 Cr (FY 2025)-16.0%Mumbai, Maharashtra, India
Pharmacare Aura Private Limited₹13.33 Cr (FY 2025)64.0%Paonta Sahib, Himachal Pradesh, India
Dymes Pharmachem Limitedthis company₹13.33 Cr (FY 2015)-17.0%Hyderabad, Telangana, India
Burnet Pharmaceuticals Pvt Ltd₹13.28 Cr (FY 2024)26.0%Kolkata, West Bengal, India
Jocund India Limited₹13.26 Cr (FY 2024)3.0%New Delhi, Delhi, India
Neiss Labs Limited₹13.26 Cr (FY 2024)54.0%Varanasi, Uttar Pradesh, India
Genees Pharmaceutical Private Limited₹13.26 Cr (FY 2025)27.0%Pune, Maharashtra, India
Zinnia Life Sciences Private Limited₹13.25 Cr (FY 2025)74.0%Coimbatore, Tamil Nadu, India

To see the full peer comparison of Dymes Pharmachem Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹5.95 Cr
Breakdown by lending institutions
State Bank of India₹4.95 Cr
The Dhanalakshmi Bank Ltd.₹1.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
01 Dec 200710087275State Bank of India₹4.95 CrSatisfied
09 Aug 200590133289The Dhanalakshmi Bank Ltd.₹1 CrSatisfied

To see the full charge records of Dymes Pharmachem Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dymes Pharmachem Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Dymes Pharmachem Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Dymes Pharmachem Limited has 11 board changes on record since 2012: 3 appointments and 8 cessations. The latest: Shilpi Singh ceased to be Additional Director on 28 Sep 2015.

Charges
A charge registered on 01 Dec 2007 via Charge ID 10087275 with State Bank Of India was fully satisfied on 17 Nov 2015.
AGM
Dymes Pharmachem Limited last Annual general meeting of members was held on 28 Sep 2015 as per latest MCA records.
Ceased
Shilpi Singh ceased to be Additional Director.
Ceased
Govinda Reddy Mettu ceased to be Director.
Filing
Dymes Pharmachem Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Hyderabad.
Appointed
Kallam Krishna Chaitanya was appointed as Whole-Time Director.
Ceased
Kallam Krishna Chaitanya ceased to be Additional Director.
Appointed
Kallam Subbareddy was appointed as Managing Director.
Ceased
Kallam Subbareddy ceased to be Additional Director.
Appointed
Shilpi Singh was appointed as Director.
Ceased
Sridevi Talluri ceased to be Director.
Ceased
Vemula Adinarayana ceased to be Managing Director.

7 earlier events are in the company report.

Frequently asked questions

Dymes Pharmachem has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Dymes Pharmachem was a public limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 16 October 1992 and is registered under CIN U51909TG1992PLC014888. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.

Dymes Pharmachem was incorporated on 16 October 1992. It is registered with the Registrar of Companies, Hyderabad.

Dymes Pharmachem had 3 directors:

The CIN (Corporate Identification Number) of Dymes Pharmachem is U51909TG1992PLC014888. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Dymes Pharmachem is at Plot No 33 S.V. Cooperative Industrial Estate. Jeedimetla, Hyderabad, Telangana, India – 500055.

Dymes Pharmachem can be reached through the website dymespharmachem.com. Its registered office is in Hyderabad, Telangana, India.

The latest financial statements of Dymes Pharmachem on record with the MCA are for the year ended 31 March 2015. Its last annual general meeting was held on 28 September 2015. Year-wise statements from 2015 are in the company report.

Dymes Pharmachem operated in the pharma industry, in the drug formulation and development segment.

The peers of Dymes Pharmachem by revenue are Seagull Laboratories (India) Private Limited, Southern Union Pharmaceuticals Kerala Private Limited, Medoz Pharmaceuticals Private Limited, Navin Saxena Research and Technology Private Limited, Pharmacare Aura Private Limited and 5 more, all in the Pharma industry (Formulations).

Dymes Pharmachem has 5 court cases on record: 4 filed by the company and 1 filed against it.